Rebalix
Logo JPMorganJPMorgan · sheet of 5 September 2026
ETF sheet · official issuer and register data

EUR IG Corporate Bond Active UCITS ETF

JREB · IE00BF59RX87 · class JPM - EUR (acc) · EUR · domicile Ireland
Bonds · Corporate EUR · Broad (all maturities) · GlobalactiveSFDR art. 8
Comparison benchmark: LECPTREU
TER
0.04%+ trans. 0.13%
Fund size
793 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.03%
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Duration
4.42 yrsmedium (3–7 years)
Launch 6 Dec 2018 · costs from the KID as of 2 Sept 2026 · 422 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The Sub-Fund aims to achieve a long-term return in excess of Bloomberg Euro Corporate Index (the "Benchmark") by actively investing primarily in a portfolio of investment grade Euro denominated corporate debt securities. Investment Policy: The investment strategy. Sub-Fund pursues an actively-managed The Sub-Fund aims to invest at least 67% of its assets (excluding assets held for ancillary liquidity purposes) in investment grade Euro denominated corporate debt securities. Issuers of these securities may be located in any country,…

Performance since series start (in euro) — base 100

6 Dec 20183 Sept 2026 · dividends reinvested where declared by the issuer
201920212023202511091108
High 110 (30 Jun 2026) · low 91 (19 Oct 2022) · last 108. Past performance is not indicative of future results.

Returns in euro

1 year+1.1%
3 years+13.1%
5 years−0.6%
10 yearsseries too young
Since series start+8.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)2.74%2.95%3.98%
Max drawdown−2.73%−2.73%−16.77%
Sharpe-0.460.32-0.63
Sortino-0.680.46-0.89
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JREB · IE00BF59RX871
RebalixJREB · IE00BF59RX87 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 94.7%
Rating breakdown (% of fund)
AAA0.1%AA1.2%A32.2%BBB61.3%< BBB2.7%Cash and derivatives2.6%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 422 securities · top-10 weight = 9.1%
Countries (% of fund)
United Kingdom17.9%United States17.9%France10.8%Netherlands8.7%Germany7.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
JREB · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BF5
Factsheet · jp.techrules.com/rebrandingPDF/LoadPdf.aspx?ShareClassId=13749&country
Prospectus · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE00BF5
The live sheet, always up to date
rebalix.com/en/etf/IE00BF59RX87
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · JREB · IE00BF59RX872